Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2023 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Nomura T, Hato S, Choda Y, Yabusaki H, Yoshida K, Misawa K, Masuzawa T, Tsuda M, Kawachi Y, Katayama H, Fukuda H, Kurokawa Y, Boku N, Sano T, Sasako M. Yoshikawa T, et al. Gastric Cancer. 2024 Jan;27(1):155-163. doi: 10.1007/s10120-023-01447-5. Epub 2023 Nov 21. Gastric Cancer. 2024. PMID: 37989806 Clinical Trial.
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306.
Shien T, Tsuda H, Sasaki K, Mizusawa J, Akiyama F, Kurosumi M, Sawaki M, Tamura N, Tanaka K, Kogawa T, Takahashi M, Hayashi N, Mukai H, Masuda N, Hara F, Iwata H. Shien T, et al. Breast Cancer Res Treat. 2024 Nov;208(1):145-154. doi: 10.1007/s10549-024-07408-5. Epub 2024 Jun 27. Breast Cancer Res Treat. 2024. PMID: 38935214 Free PMC article. Clinical Trial.
A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).
Nishimura Y, Ishikura S, Shibata T, Kodaira T, Ito Y, Tsuchiya K, Murakami Y, Saitoh JI, Akimoto T, Nakata K, Yoshimura M, Teshima T, Toshiyasu T, Ota Y, Ishikawa K, Shimizu H, Minemura T, Nakamura K, Hiraoka M. Nishimura Y, et al. Int J Clin Oncol. 2020 Jul;25(7):1250-1259. doi: 10.1007/s10147-020-01665-2. Epub 2020 Mar 27. Int J Clin Oncol. 2020. PMID: 32221802 Clinical Trial.